Mar 7
|
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
|
Nov 30
|
BioXcel Therapeutics to Host Virtual Neuroscience R&D Day on Dec. 12, 2023
|
Oct 31
|
BioXcel Therapeutics to Report Third Quarter 2023 Financial Results on November 14, 2023
|
Oct 30
|
BioXcel Therapeutics Receives Permanent J-Code for IGALMI™ (dexmedetomidine) Sublingual Film from Centers for Medicare & Medicaid Services
|
Oct 4
|
BioXcel Therapeutics Provides Update on Recent Developments for Late-Stage Clinical Programs and Expansion of IP Portfolio for IGALMI™ (dexmedetomidine) Sublingual Film
|